Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Beardsley Robert A, Chief Operating Officer. Insider active across 1 company, notably Galera Therapeutics, Inc.. In total, 3 disclosures have been published. History available since 17 December 2021. The latest transaction was disclosed on 21 November 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Robert A. Beardsley is the Chief Operating Officer at Galera Therapeutics, Inc., a biopharmaceutical company. In his role, he oversees the daily operations of the company and ensures that operational objectives are met. His experience in the biopharmaceutical sector allows him to optimize processes and improve efficiency.